NovaBay Pharmaceuticals to Present at the Rodman & Renshaw Global Investment Conference

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its Avenova® lid and lash hygiene for the domestic eye care market, announces that President and CEO Mark M. Sieczkarek will present at the Rodman & Renshaw 18th Annual Global Investment Conference on Tuesday, September 13, 2016, at 12:30 p.m. Eastern time (9:30 a.m. Pacific time). The conference is being held at the Palace Hotel in New York City. A li